Edap Tms (EDAP) Competitors

Edap Tms (NASDAQ:EDAP) and AxoGen (NASDAQ:AXGN) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, media sentiment, community ranking, valuation and earnings.

Is EDAP or AXGN more profitable?

AxoGen has a net margin of -12.99% compared to Edap Tms' net margin of -35.03%. AxoGen's return on equity of -21.96% beat Edap Tms' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Edap Tms	-35.03%	-34.33%	-22.28%
AxoGen	-12.99%	-21.96%	-10.95%

Which has more risk and volatility, EDAP or AXGN?

Edap Tms has a beta of 0.65, meaning that its share price is 35% less volatile than the S&P 500. Comparatively, AxoGen has a beta of 1.07, meaning that its share price is 7% more volatile than the S&P 500.

Do analysts prefer EDAP or AXGN?

Edap Tms currently has a consensus target price of $14.67, suggesting a potential upside of 105.42%. AxoGen has a consensus target price of $10.67, suggesting a potential upside of 84.23%. Given Edap Tms' higher possible upside, research analysts clearly believe Edap Tms is more favorable than AxoGen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Edap Tms	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
AxoGen	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Does the MarketBeat Community believe in EDAP or AXGN?

AxoGen received 101 more outperform votes than Edap Tms when rated by MarketBeat users. Likewise, 72.59% of users gave AxoGen an outperform vote while only 62.77% of users gave Edap Tms an outperform vote.

Company	Underperform	Outperform
Edap Tms	Outperform Votes 344 62.77%	Underperform Votes 204 37.23%
AxoGen	Outperform Votes 445 72.59%	Underperform Votes 168 27.41%

Do institutionals & insiders have more ownership in EDAP or AXGN?

62.7% of Edap Tms shares are held by institutional investors. Comparatively, 80.3% of AxoGen shares are held by institutional investors. 0.2% of Edap Tms shares are held by insiders. Comparatively, 7.2% of AxoGen shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Which has better earnings & valuation, EDAP or AXGN?

AxoGen has higher revenue and earnings than Edap Tms. AxoGen is trading at a lower price-to-earnings ratio than Edap Tms, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Edap Tms	$65.42M	4.05	-$22.92M	-$0.63	-11.33
AxoGen	$159.01M	1.59	-$21.72M	-$0.50	-11.58

Does the media prefer EDAP or AXGN?

In the previous week, AxoGen had 8 more articles in the media than Edap Tms. MarketBeat recorded 10 mentions for AxoGen and 2 mentions for Edap Tms. Edap Tms' average media sentiment score of 0.59 beat AxoGen's score of -0.23 indicating that Edap Tms is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Edap Tms	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
AxoGen	1 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

AxoGen beats Edap Tms on 13 of the 17 factors compared between the two stocks.